Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Otolaryngol Head Neck Surg. 2013 Jun 26;149(3):10.1177/0194599813495179. doi: 10.1177/0194599813495179

Table 1.

Patient demographics and hearing thresholds in the affected ear.

Affected Ear Thresholds

Case Affected
Ear
Gender Agea 3fPTA
Pre
FFPTA
Pre
3fPTA
3 mob
FFPTA
3 mo
3fPTA
6 mo
FFPTA
6 mo
1c R F 28 70.0 73.1 120.0 120.0 120.0 120.0
2 R M 50 50.0 55.7 120.0 120.0 120.0 120.0
3 R F 43 46.7 54.4 120.0 120.0 NAd NA
4 R M 45 15.0 33.1 120.0 120.0 120.0 120.0
5 R F 47 30.0 48.1 33.3 48.8 35.0 49.4
6 L M 39 48.3 46.7 120.0 120.0 120.0 120.0
7 L M 52 43.3 61.3 50.0 63.8 NA NA
8 L F 56 35.0 38.3 36.7 50.0 38.3 40.8
9 L F 53 18.3 28.1 61.7 65.8 61.7 61.1

Mean 45.9 39.6 48.8 86.9 92.0 87.9 90.2
SEM 2.9 5.7 4.7 13.4 11.2 15.5 14.2
Tumor size and location per case.
Case Size (cm) Volume Location Treatmente
1 n/af n/a n/a SR vestibular nerve
2 3.4 × 3.2 CPA, residual tumor Radical subtotal SR followed with GK
3 2 CPA, extending in SR
4 2.7 × 2.2 × CPA, extending in SR followed with GK
5 0.5 × 1 IAC Middle fossa craniotomy
6 1.6 × 2.1 × CPA Sub-occipital craniotomy with SR
7 1.2 × 1 683.4 CPA, extending in GK
8 0.6 217 IAC mid canal GK
9 1700 CPA, extending in GK
a

Age at time of study enrollment.

b

One hundred twenty assigned to all thresholds with no response to test equipment limits.

c

Case 1 had Meniere’s syndrome.

d

Patient not available for threshold testing or imaging scans, NA.

a

Cerebellopontine angle (CPA); intracanalicular (IAC).

b

Treatments included Gamma Knife radiosurgery, GK and surgical resection, SR.

c

Not applicable (n/a); other dimensions as noted by surgeons in the patient records.